Citation Impact

Citing Papers

Extracellular NAD and ATP: Partners in immune cell modulation
2007
Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
2011 Standout
Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade
2008 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer
2015
A Comparative Study of Interleukin-1β Production and P2x7 Expression After Atp Stimulation by Peripheral Blood Mononuclear Cells Isolated From Rheumatoid Arthritis Patients and Normal Healthy Controls
2007
Immunogenic cell death in cancer and infectious disease
2016 Standout
Machine learning applications in cancer prognosis and prediction
2014 Standout
C-terminal Calmodulin-binding Motif Differentially Controls Human and Rat P2X7 Receptor Current Facilitation
2010
The P2X7 Nucleotide Receptor Mediates Skeletal Mechanotransduction
2005
Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment
2007
Significance of P2X7 Receptor Variants to Human Health and Disease
2011
An Ile-568 to Asn Polymorphism Prevents Normal Trafficking and Function of the Human P2X7 Receptor
2003
Residues 155 and 348 Contribute to the Determination of P2X7 Receptor Function via Distinct Mechanisms Revealed by Single-nucleotide Polymorphisms
2011
Meta-analysis of nitrogen balance studies for estimating protein requirements in healthy adults
2003
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
Evidence-Based Recommendations for Optimal Dietary Protein Intake in Older People: A Position Paper From the PROT-AGE Study Group
2013 Standout
The immunology of stroke: from mechanisms to translation
2011 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Sterile inflammation: sensing and reacting to damage
2010 Standout
C terminus of the P2X7 receptor: treasure hunting
2011
Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation
2006
Diets rich in Maillard reaction products affect protein digestibility in adolescent males aged 11–14 y
2006
P2X7 receptor polymorphism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation
2007
An estimation of mineral losses through arm sweat of preadolescent children
1976
Physiology of sweat gland function: The roles of sweating and sweat composition in human health
2019 Standout
Predictive Models for Breast Cancer Susceptibility from Multiple Single Nucleotide Polymorphisms
2004
Glu496 to Ala Polymorphism in the P2X7 Receptor Impairs ATP-Induced IL-1β Release from Human Monocytes
2004
Immunological and Inflammatory Functions of the Interleukin-1 Family
2009 Standout
The Inflammasomes: Guardians of the Body
2009 Standout
A His-155 to Tyr Polymorphism Confers Gain-of-Function to the Human P2X7 Receptor of Human Leukemic Lymphocytes
2005
Receptors for Purines and Pyrimidines
2012 Standout
The amazing osteocyte
2010 Standout
Exacerbation of Experimental Autoimmune Encephalomyelitis in P2X7R−/− Mice: Evidence for Loss of Apoptotic Activity in Lymphocytes
2006
Hydroxymethylfurfural, A Versatile Platform Chemical Made from Renewable Resources
2013 Standout

Works of John Taper being referenced

A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study
2002
Outpatient-based ifosfamide, carboplatin and etoposide (ICE) chemotherapy in transplant-eligible patients with non-Hodgkin’s lymphoma and Hodgkin’s disease
2003
The effects of sweat nitrogen losses in evaluating protein utilization by preadolescent children
1976
Outpatient fractionated ifosfamide, carboplatin and etoposide as salvage therapy in relapsed and refractory non-Hodgkin's and Hodgkin's lymphoma
2006
Rankless by CCL
2026